DEEP Missions

We have a vision where pharma, academia, patient groups, technology providers and regulators collaborate pre-competitively to build regulatory-ready digital measures that can be shared and reused across drug development - to help improve the lives of patients. DEEP provides the platform, tools and services that make this kind of collaboration possible.

Browse the missions below - some are open for collaborators now, others are still being scoped. If you have one to propose, we would love to hear from you.

  • There are no suggestions because the search field is empty.

The MG Harmonization Mission: from fragmentation to framework in myasthenia gravis

Myasthenia gravis has become one of the most competitive therapeutic areas in neurology, with multiple approved targeted therapies competing across overlapping patient populations. That is good news...

UCB Led Mission - to Measure What Matters in Respiratory Disease

Originally published May 14, 2026 · Updated Aug 4, 2026. Digital measurement is increasingly used in respiratory drug development, but the field remains fragmented. Across indications, similar...

Unifying Digital Measures in Parkinson's Disease

Building Digital Measures for PD? DEEP can help! Clinical trials in PD have relied on snapshot, clinic-based assessments for too long. We're changing that: bringing pharma, biotech, researchers,...

DEEP/NICE Advice pilot mission: The way medicines reach European patients has changed - the time to prepare is now!

Why this matters now ? Authorities increasingly want exactly what digital measures are built to deliver: continuous, patient-relevant outcomes from wearables, sensors and apps. At the same time, the...